16 completed, 3 unknown, 2 recruiting, 1 active not recruiting. 13 Phase 1, 4 Phase 2, 3 Not applicable, 3 Phase 3, 1 Phase 4.
Follow Dorzagliatin: new trials by email Literature Review of Dorzagliatin trials Research Report on Dorzagliatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on Improving Blood Glucose Homeostasis With Dorzagliatin Tablets in the Treatment of Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal Insufficiency Dorzagliatin, Linagliptin - Type 2 Diabetes Mellitus (T2DM), Chronic Renal Insufficiency | Not applicable | Withdrawn | Sun Yat-sen University | 2026-12-01 | 2026-10-16 | |
| Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis Dorzagliatin, Placebo - Pancreatic Insufficiency, Cystic Fibrosis-related Diabetes | Phase 1 | Recruiting | Michael R. Rickels, MD, MS | 15 | 2025-10-21 | 2026-08-31 |
| Glucokinase Activator in Monogenic Diabetes Dorzagliatin, matched placebo - Diabetes Mellitus, Monogenic Diabetes | Phase 2 | Recruiting | Chinese University of Hong Kong | 44 | 2025-04-30 | 2026-04-30 |
| Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes Dorzagliatin - Diabetes Mellitus, Prediabetes / Type 2 Diabetes | Not applicable | Not yet recruiting | Elaine Chow | 30 | 2025-04-02 | 2025-03-04 |
| Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study. Dorzagliatin, Gliclazide - Diabetic Nephropathy Type 2 | Not applicable | Unknown | Yan Bi | 106 | 2024-02-20 | 2024-01-24 |
| A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes Dorzagliatin tablets - Type2diabetes | Phase 4 | Completed | Hua Medicine Limited | 2024 | 2024-01-17 | 2026-07-10 |
| Dorzagliatin and 1st Phase Insulin and Beta-cell Glucose Sensitivity in IGT and NGT Dorzagliatin, Placebo - Glucose Intolerance | Phase 1 / Phase 2 | Unknown | Chinese University of Hong Kong | 20 | 2022-08-01 | 2022-07-25 |
| Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity Metformin, Insulin Glargine, Dorzagliatin - Type 2 Diabetes | Phase 3 | Active not recruiting | University of Alabama at Birmingham | 100 | 2022-03-07 | 2025-07-30 |
| Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Dorzagliatin, placebo - Diabetes Mellitus, Type 2 | Phase 2 | Completed | Chinese University of Hong Kong | 18 | 2020-09-30 | 2022-07-22 |
| A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers HMS5552 - Type 2 Diabetes Mellitus | Phase 1 | Completed | Hua Medicine Limited | 17 | 2019-04-23 | 2020-03-27 |
| Drug Interaction Study Between Dorzagliatin and Empagliflozin Empagliflozin, Dorzagliatin - Patients | Phase 1 | Completed | Hua Medicine Limited | 16 | 2019-04-18 | 2025-03-24 |
| A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers HMS5552 - Type 2 Diabetes Mellitus | Phase 1 | Completed | Hua Medicine Limited | 25 | 2019-02-18 | 2022-11-29 |
| Drug Interaction Study Between Dorzagliatin and Sitagliptin Sitagliptin, Dorzagliatin - Patients | Phase 1 | Completed | Hua Medicine Limited | 15 | 2019-01-31 | 2023-02-28 |
| The Progress of Diabetes Mellitus After HMS5552 Treatment in Type 2 Diabetes Mellitus HMS5552 - Type2 Diabetes Mellitus | Unknown | Majianhua | 24 | 2018-12-12 | 2021-08-26 | |
| DDI Study Between Dorzagliatin and Rifampicin Dorzagliatin - Drug Interaction | Phase 1 | Completed | Hua Medicine Limited | 15 | 2018-03-27 | 2019-09-06 |
| Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects HMS5552, Placebo - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Hua Medicine Limited | 767 | 2017-10-15 | 2021-08-26 |
| DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin Dorzagliatin - Drug Interaction | Phase 1 | Completed | Hua Medicine Limited | 18 | 2017-10-13 | 2019-09-06 |
| Long-term Efficacy and Safety of HMS5552 in T2DM Subjects HMS5552, Placebo - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Hua Medicine Limited | 463 | 2017-07-18 | 2021-08-26 |
| Human Mass Balance Study of HMS5552 in Healthy Subjects HMS5552 - Healthy Subject | Phase 1 | Completed | Hua Medicine Limited | 6 | 2017-03-29 | 2018-12-31 |
| Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM Metformin, HMS5552 - Type 2 Diabetes Mellitus | Phase 1 | Completed | Hua Medicine Limited | 12 | 2015-10-01 | 2016-02-17 |
Showing 20 of 24. Sign in to see all of them.
Diabetes Mellitus, Type 2 (13) · Diabetes Mellitus (2) · Exocrine Pancreatic Insufficiency (1) · Glucose Intolerance (1) · Prediabetic State (1) · Renal Insufficiency, Chronic (1)
Hua Medicine Limited (15) · Chinese University of Hong Kong (3) · Elaine Chow (1) · Majianhua (1) · Michael R. Rickels, MD, MS (1) · Sun Yat-sen University (1) · University of Alabama at Birmingham (1) · Yan Bi (1)
China (13) · United States (6) · Hong Kong (3)
Gregory J Tracey, MD (2) · Charles Tomek, MD (1) · Dalong Zhu, MD,PhD (1) · Dalong Zhu, PhD (1) · Elaine Chow, MBChB, PhD, FRCP (1) · Gregory Tracey, MD (1) · Jia Miao, MD (1) · Michael R Rickels, MD, MS (1) · Ping Fu, MD (1) · Wenying Yang, MD (1) · XueNing LI, MD (1) · Yanbing Li (1)
PMID 29735394, PMID 34706161, PMID 35551292, PMID 42014686
R01DK029953 (1)